Unknown

Dataset Information

0

Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients.

ABSTRACT:

SUBMITTER: Koning R 

PROVIDER: S-EPMC8034036 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients.

Koning Rutger R   Bastard Paul P   Casanova Jean-Laurent JL   Brouwer Matthijs C MC   van de Beek Diederik D  

Intensive care medicine 20210409 6

Similar Datasets

Unknown Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis.
| S-EPMC10005838 | biostudies-literature
Unknown Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia.
| S-EPMC7899072 | biostudies-literature
Unknown Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma.
| S-EPMC8132742 | biostudies-literature
Unknown Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
| S-EPMC9286229 | biostudies-literature
Unknown Increased blood immune regulatory cells in severe COVID-19 with autoantibodies to type I interferons.
| S-EPMC10575900 | biostudies-literature
Unknown Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital.
| S-EPMC8791677 | biostudies-literature
Unknown Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital.
| S-EPMC8491850 | biostudies-literature
Unknown Type I Interferons in COVID-19 Pathogenesis.
| S-EPMC8468334 | biostudies-literature
Unknown Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
| S-EPMC7334951 | biostudies-literature
Unknown Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
| S-EPMC8279584 | biostudies-literature